Skip to main content

and
  1. Article

    Open Access

    Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma

    Recent clinical studies have suggested that programmed death ligand 1 (PD-L1) expression in a tumour could be a potential biomarker for PD-L1/PD-1 blockade therapies.

    Chao-Qun Liu, **g Xu, Zhong-Guo Zhou, Li-Lian ** in British Journal of Cancer (2018)